About the Authors

Michael Eddleston
Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, United Kingdom

Michael Eddleston, Fahim Mohamed, Lalith Senarathna, Mohamed Hussain Rezvi Sheriff
Ox-Col Collaboration, Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Sri Lanka

Michael Eddleston, Fahim Mohamed, Lalith Senarathna, Andrew H. Dawson, Mohamed Hussain Rezvi Sheriff, Nick A. Buckley
South Asian Clinical Toxicology Research Collaboration, Sri Lanka

Peter Eyer
Walther Straub Institute of Pharmacology and Toxicology, Ludwig Maximilians University, Munich, Germany

Franz Worek
Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany

Edmund Juszczak, Nicola Alder
Centre for Statistics in Medicine, Wolfson College, University of Oxford, England

Ariyasena Hittarage, K. Jeganathan
Anuradhapura General Hospital, North Central Province, Sri Lanka

Shifa Azher, Shaluka Jayamanne
Polonnaruwa General Hospital, North Central Province, Sri Lanka

Ludwig von Meyer
Institute of Legal Medicine, Ludwig Maximilians University, Munich, Germany

Andrew H. Dawson
School of Public Health, University of Newcastle, Australia

Nick A. Buckley
Professorial Unit, Department of Medicine, University of New South Wales, Sydney, Australia

Corresponding Author

eddlestonm@yahoo.com

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

ICMJE criteria for authorship read and met: ME PE FW EJ NA FM LS AH SA KJ SJ LvM AHD NAB. Agree with the manuscript's results and conclusions: ME PE FW EJ NA FM LS AH SA KJ SJ LvM AHD MHRS NAB. Designed the experiments/the study: ME FW EJ MHRS NAB. Analyzed the data: ME PE FW FM AHD MHRS. Collected data/did experiments for the study: ME PE FW NA LS AH KJ LvM NAB. Enrolled patients: ME LS AH SA KJ SJ. Wrote the first draft of the paper: ME. Contributed to the writing of the paper: ME PE FW EJ NA FM LS SA AHD MHRS NAB. Responsible for the analyses of the PK/PD data: PE. Determination of cholinesterase data and analysis of cholinesterase, pesticide and oxime data: FW. Conducted the randomisation with the trial programmer, and performed interim analysis for the Chair of the Independent Data Monitoring Committee: EJ. Ran the logistics of this study in one of the centres and was involved in data auditing: FM. Contributed to the study at the initial stage of designing: SJ. Responsible for poison concentration data: LvM. Oversaw the two clinical centres involved in the study, examined and validated the primary data: AHD.